ReviewFrontiers in immunology2025

Advances in the study of reversing tumor drug resistance by targeting cancer-associated fibroblasts with nanomaterials.

Xiaozhuo Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.